Treprostinil therapy for pulmonary artery hypertension

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.11, 2002-11, pp. : 1615-1622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Treprostinil in the Management of Pulmonary Hypertension

By Skoro-Sajer Nika Lang Irene

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 4, 2008-01 ,pp. : 213-217

Adis International

Access to resources Recommend Favorite

Continuous SC treprostinil sodium effective in pulmonary hypertension

Inpharma, Vol. 1, Iss. 1332, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Inhaled treprostinil is an effective, well-tolerated add-on therapy for patients with pulmonary arterial hypertension (PAH) treated with bosentan

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Optimal Use of Treprostinil in Pulmonary Arterial Hypertension: A Guide to the Correct Use of Different Formulations

By Skoro-Sajer Nika

Drugs, Vol. 72, Iss. 18, 2012-12 ,pp. : 2351-2363

Adis International

Access to resources Recommend Favorite

A Clinical Comparison of Slow- and Rapid-Escalation Treprostinil Dosing Regimens in Patients with Pulmonary Hypertension

By Skoro-Sajer Nika

Clinical Pharmacokinetics, Vol. 47, Iss. 9, 2008-01 ,pp. : 611-618

Adis International

Access to resources Recommend Favorite